Meridian Bioscience, Inc. (VIVO), a leading provider of diagnostic testing solutions and life science raw materials, is pleased to announce its collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for laboratory use. Since the beginning of the coronavirus outbreak, Meridian has enabled the manufacture of millions of COVID-19 assays through its partnerships with over 35 diagnostic companies around the globe. In the last few months, Meridian has multiplied its production capabilities to meet the demand of its customers including QuantuMDx.

The RCS rollout continues across the globe. RCS is an upgrade to the standard SMS messaging feature set that exists on all smartphones. It adds typing indicators, read receipts, emoji reactions, support for higher quality file sharing, and so on. In essenc…

CINCINNATI, March 16, 2020 -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of immunoassay, molecular, and blood chemistry diagnostic testing solutions, today announced.

Researchers have developed a method to accurately assess the effect of specific drugs in isolated pancreatic tissue by using a refined single-cell RNA sequencing method.

The impact of COVID-19 on smartphone sales was drastic, as market analysts noted shipments worldwide dropped by millions in the last few months. While manufacturers are typically nonspecific about sales numbers, IDC’s Quarterly Mobile Phone tracker noted this…

Huawei is facing an uphill challenge in the overseas market as its upcoming devices lack the full set of Google apps and services. That leaves ample room for its Chinese rivals to chase after foreign consumers. That includes Oppo, the sister brand of Vivo und…

Xiaomi continued to lead the Indian smartphone market with 30.6% share in Q1 2020. What you need to know BBK-owned smartphone maker Vivo overtook Samsung to emerge as the second largest smartphone vendor in India in Q1 2020. Vivo shipped 6.7 million smar…

Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CINCINNATI, April 14, 2020 -- Meridian Bioscience, Inc. (NASDAQ: VIVO), announced today the launch of several novel recombinant antigens critical for the development of.

Meridian Bioscience, Inc.’s (VIVO) Board of Directors announced that Tony Serafini-Lamanna has been promoted to Executive Vice President of Diagnostics. Jack Kenny remains Chief Executive Officer of Meridian, while passing responsibility of the Diagnostics division to Mr. Serafini-Lamanna, who becomes an officer of the company.

The Mi 10 has a lot to offer, but the 108MP camera alone isn't enough to give it an edge in this segment. When you think of Xiaomi in India, the first thing that comes to mind is its Redmi phones. Although Redmi is now a standalone entity, Xiaomi and Redmi…

In March, when India announced its first lockdown to curb the coronavirus spread, major smartphone makers such as Xiaomi, Samsung, Oppo, and Vivo had to shut down factories. Now, as the country’s government is slowly lifting restrictions, these companies are …

Apple was the third-fastest growing brand in India's smartphone market in the first quarter of this year, according to new data from Counterpoint Research. Apple achieved 78 percent growth as the overall market in the country grew 4 percent year on year…

It will also include a periscope zoom lens. What you need to know Vivo's upcoming X50 flagship phone will have a humongous gimbal-style camera lens. It is rumored to be the first phone to come equipped with Samsung's new ISOCELL GN1 camera sensor. The Vi…

CINCINNATI, April 16, 2020 -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report second quarter.

Earlier this month, India officially launched its coronavirus contact tracing app named Aarogya Setu. Within weeks it has reached the milestone of 80 million downloads. Now, the government wants smartphone makers to pre-install the app in their devices. Accor…

Xiaomi may be collecting more data than users are aware of, but the company says it's doing so strictly within legal limits. What you need to know Xiaomi has been accused of collecting more data than would reasonably be anticipated from smartphone users.…

MIUI 12 brings a lot of visual tweaks and fine-tuned control over privacy settings. MIUI continues to be one of the most popular Android skins around, with over 400 million users around the world. Xiaomi being the number one handset manufacturer in India m…

Xiaomi has announced a new ecommerce platform called Mi Commerce to let local stores sell the company’s products — including phones, Mi TVs, and power banks — online. The idea is to connect these stores directly to consumers through a web app or WhatsApp to s…

The coronavirus-focused stock rises notably on news of yet another partnership with a diagnostics company.

Samsung shipped over 8.3 million 5G-enabled smartphones during the quarter. What you need to know Samsung shipped more 5G smartphones than any other brand in Q1 2020. It held a 34.4% share of the global market in the January-March period. Huawei was a c…

Meridian Bioscience, Inc. (VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided a business update including preliminary revenue results for its second quarter of fiscal 2020. The Company expects second quarter of fiscal 2020 revenues to be approximately $57 million, compared to $50.2 million in the second quarter of fiscal 2019.

Two Medical Products Stocks with Recent Price Strength.

In order to help expedite such development, Meridian is pleased to provide from stock its specialized enzyme formulations to manufacturers of a COVID-19 molecular detection assay at no cost for the purpose of initial testing and evaluation. Following the successful development of a COVID-19 detection assay or kit, it is Meridian’s commitment to continue to manufacture and supply its propriety formulations at commercial scale in order to meet the global demand.

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 187.50% and 0.52%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Xiaomi today launched a new e-commerce service in India that allows people in the nation to easily browse and order its handsets and other products from nearby physical retail stores as the Chinese giant rushes to kickstart its sales in its biggest overseas m…

The Life Science segment achieved record sales in the quarter, produced by unprecedented demand for products specifically designed for the detection of RNA viruses such as SARS-CoV-2.

Jack Kenny has been the CEO of Meridian Bioscience, Inc. (NASDAQ:VIVO) since 2017. First, this article will compare...

Shares of Meridian Bioscience (NASDAQ:VIVO) rose 8.4% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share were up 21.05% year over year to $0.23, which beat the estimate of $0.08.Revenue of $57,296,000 rose by 14.03% from the same period last year, which beat the estimate of $49,260,000.Guidance Meridian Bioscience hasn't issued any earnings guidance for the time being.Revenue guidance hasn't been issued by the company for now.How To Listen To The Conference Call Date: May 08, 2020View more earnings on VIVOTime: 11:03 PM ETWebcast URL: https://investor.meridianbioscience.com/events/event-details/q2-2020-financial-results-conference-callPrice Action Company's 52-week high was at $16.4252-week low: $5.51Price action over last quarter: Up 126.72%Company Overview Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment contributes the majority of revenue & manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.See more from Benzinga * Stocks That Hit 52-Week Highs On Thursday * Stocks That Hit 52-Week Highs On Wednesday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

40.8 million handsets were shipped in April. What you need to know China's Smartphone shipments have seen a big increase in April. They are up 17% compared to last year. It could signal that companies like Huawei are seeing a resurgence in demand following…

CINCINNATI, May 08, 2020 -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2020. Second Quarter Fiscal.

Even though Fitbit has been in the wearable space for over a decade, the company is still relatively fresh to the kids market. That's about to change soon. A source close to the matter told Engadget that Fitbit will launch a kids smartwatch with 4G connectivi…

CINCINNATI, May 26, 2020 -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that.

Meridian Bioscience, Inc. (VIVO) announced today the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step RT-qPCR Mix) that eliminates the need to use an RNA extraction kit prior to running the patient sample through a molecular assay. To date, most COVID-19 molecular assays require laboratories to first isolate and purify the SARS-CoV-2 viral RNA from a patient sample (saliva or nasopharyngeal). To address these shortfalls, scientists at Meridian have successfully developed a proprietary master mix formulation, which when combined with SARS-CoV-2 primers and probes, will enable laboratories to eliminate the SARS-CoV-2 viral RNA purification step.

Q2 2020 Meridian Bioscience Inc Earnings Call

Have you heard of an app called Glance? Maybe not, but if you’re using a Xiaomi, Samsung, or a Vivo phone in India, Indonesia, or Malaysia, you might’ve used it. For those unfamiliar, Glance is a lock screen app showing trending topics — and it recently reach…

Meridian Bioscience, Inc. (VIVO), a provider of diagnostic testing solutions and life science raw materials, has completed its previously announced acquisition of Exalenz Bioscience Ltd., the Modiin, Israel based provider of the BreathID® Breath Test Systems, a urea breath test platform for the detection of Helicobacter pylori. According to the CDC, approximately two thirds of the global population is infected with H. pylori, a leading cause of peptic ulcers and gastric cancer.

Vivo teased some pretty ambitious tech with its Apex 2020 concept phone, but now it’s putting one of those far-out innovations into something you might actually be able to buy.Read more...

With me are Jack Kenny, Chief Executive Officer; and Bryan Baldasare, Chief Financial Officer. With regards to our calendar, Jack and Bryan will be participating in a virtual fireside chat as part of the William Blair Annual Growth Stock Conference on Tuesday, June 9, 2020.

Although sonar or lidar are used by autonomous vehicles to detect nearby objects, these approaches incur significant equipment and signal-processing costs. Nakata et al. show that mosquitos detect surfaces using the flow fields caused by the movement of their…